Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial
- 1 October 2006
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 368 (9544) , 1349-1356
- https://doi.org/10.1016/s0140-6736(06)69559-7
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malariaTropical Medicine & International Health, 2005
- Effectiveness of Antimalarial DrugsNew England Journal of Medicine, 2005
- A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in GhanaTropical Medicine & International Health, 2005
- Can amodiaquine be used safely during pregnancy?The Lancet Infectious Diseases, 2004
- The efficacy of antimalarial monotherapies, sulphadoxine–pyrimethamine and amodiaquine in East Africa: implications for sub‐regional policyTropical Medicine & International Health, 2003
- Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidaeTropical Medicine & International Health, 2001
- The burden of malaria in pregnancy in malaria-endemic areasThe American Journal of Tropical Medicine and Hygiene, 2001
- Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in ThailandTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Systematic review of amodiaquine treatment in uncomplicated malariaThe Lancet, 1996
- A randomized trial of chloroquine, amodiaquine and pyrimethamine‐sulphadoxine in Gambian children with uncomplicated malariaTropical Medicine & International Health, 1996